Stephen M. Ansell, MD, PhD

Professor of Medicine, Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA

Stephen M. Ansell, MD, PhD, is a consultant in the Division of Hematology, Department of Internal Medicine, at Mayo Clinic. He holds the academic rank of Professor of Medicine, Mayo Clinic College of Medicine. He received his medical degree at the University of Pretoria, South Africa and subsequently completed his Ph.D. at the same institution. He trained in medical oncology before coming to the United States. Dr. Ansell then completed a residency in Internal Medicine and a fellowship in Hematology and Oncology at Mayo Clinic.

Dr. Ansell’s clinical practice interests focus on non-Hodgkin lymphoma, Hodgkin’s disease, and Waldenstrom’s macroglobulinemia. His research focuses on the biology of these diseases and on developing new therapies. He receives funding for research from the National Institutes of Health, the Leukemia and Lymphoma Society, and the International Waldenstrom’s Macroglobulinemia Foundation.

Dr. Ansell is Chair of the Mayo Clinic Lymphoma Group as well as Chair of the Faculty Development and Recruitment for Hematology at Mayo. He has been honored with various awards during his training and career, including the Department of Medicine New Investigator at Mayo Clinic and Medical Honoree at the Lymphoma Research Foundation, Minnesota Chapter.  He has held memberships with organizations including the American Association for Cancer Research, the American Medical Association, the American Society of Clinical Oncology, and the Eastern Cooperative Oncology Group.  He has served on the editorial boards of the American Journal of Hematology, Journal of Clinical Oncology, Blood Cancer Journal and Clinical Lymphoma and Myeloma.  Dr. Ansell has co-authored more than 330 articles in peer-reviewed journals.